JPWO2021005339A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021005339A5 JPWO2021005339A5 JP2022500080A JP2022500080A JPWO2021005339A5 JP WO2021005339 A5 JPWO2021005339 A5 JP WO2021005339A5 JP 2022500080 A JP2022500080 A JP 2022500080A JP 2022500080 A JP2022500080 A JP 2022500080A JP WO2021005339 A5 JPWO2021005339 A5 JP WO2021005339A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- cell
- cells
- nucleic acid
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19184742 | 2019-07-05 | ||
| EP19184742.5 | 2019-07-05 | ||
| PCT/GB2020/051594 WO2021005339A1 (en) | 2019-07-05 | 2020-07-03 | Novel cancer antigens and methods |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022539585A JP2022539585A (ja) | 2022-09-12 |
| JP2022539585A5 JP2022539585A5 (https=) | 2023-07-13 |
| JPWO2021005339A5 true JPWO2021005339A5 (https=) | 2023-07-13 |
| JP7834016B2 JP7834016B2 (ja) | 2026-03-23 |
Family
ID=67211535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500080A Active JP7834016B2 (ja) | 2019-07-05 | 2020-07-03 | 新規な癌抗原及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220211760A1 (https=) |
| EP (1) | EP3994156A1 (https=) |
| JP (1) | JP7834016B2 (https=) |
| KR (1) | KR20220034039A (https=) |
| CN (2) | CN114174323B (https=) |
| AU (1) | AU2020312230A1 (https=) |
| BR (1) | BR112022000133A2 (https=) |
| CA (1) | CA3141990A1 (https=) |
| IL (1) | IL289334A (https=) |
| MX (1) | MX2022000262A (https=) |
| WO (1) | WO2021005339A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021006941A2 (pt) | 2018-10-19 | 2021-08-31 | The Francis Crick Institute Limited | Antígenos de câncer inovadores e métodos |
| TW202241925A (zh) | 2021-01-15 | 2022-11-01 | 德商英麥提克生物技術股份有限公司 | 用於不同類型癌症免疫治療的ｈｌａ展示肽 |
| US20250054576A1 (en) | 2021-12-17 | 2025-02-13 | Evaxion Biotech A/S | Personalized cancer therapy targeting normally non-expressed sequences |
| WO2025202937A1 (en) | 2024-03-26 | 2025-10-02 | BioNTech SE | Cancer vaccines |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002515734A (ja) | 1996-01-02 | 2002-05-28 | カイロン コーポレイション | 遺伝子改変された樹状細胞により媒介される免疫刺激 |
| US6770456B1 (en) | 1998-07-29 | 2004-08-03 | Ludwig Institute For Cancer Research | Endogenous retrovirus tumor associated nucleic acids and antigens |
| US20020015998A1 (en) | 2000-04-06 | 2002-02-07 | Gabriel Vogeli | Novel G protein-coupled receptors |
| US7193069B2 (en) * | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
| EP1586330A1 (en) | 2004-04-16 | 2005-10-19 | Georg-August-Universität Göttingen | Vaccination against malignant melanoma |
| DK1871391T3 (da) | 2005-03-30 | 2012-04-16 | Viroxis | Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling |
| AT502292B1 (de) | 2005-05-11 | 2010-04-15 | Avir Green Hills Biotechnology | Melanomdiagnose |
| US8921050B2 (en) | 2006-03-17 | 2014-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of diagnosing renal cell carcinoma |
| US20080019979A1 (en) | 2006-05-22 | 2008-01-24 | Feng Wang-Johanning | HERV-K Antigens, Antibodies, and Methods |
| US20100120627A1 (en) * | 2006-08-02 | 2010-05-13 | Abdelmajid Belouchi | Genemap of the human genes associated with psoriasis |
| WO2009026116A2 (en) * | 2007-08-16 | 2009-02-26 | Genizon Biosciences, Inc. | Genemap of the human genes associated with longevity |
| GB201521746D0 (en) * | 2015-12-10 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers |
| GB201521894D0 (en) * | 2015-12-11 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various cancers |
| CR20180551A (es) * | 2016-04-21 | 2019-02-12 | Immatics Biotechnologies Gmbh | Inmunoterapia contra el melanoma y otros tipos de cáncer |
| US10384736B2 (en) * | 2016-07-13 | 2019-08-20 | Marcelo A. Pizarro | Dual oscillating cycle saddle and support system |
-
2020
- 2020-07-03 JP JP2022500080A patent/JP7834016B2/ja active Active
- 2020-07-03 KR KR1020217040818A patent/KR20220034039A/ko not_active Ceased
- 2020-07-03 MX MX2022000262A patent/MX2022000262A/es unknown
- 2020-07-03 CA CA3141990A patent/CA3141990A1/en active Pending
- 2020-07-03 CN CN202080049064.4A patent/CN114174323B/zh active Active
- 2020-07-03 CN CN202411890938.5A patent/CN120005001A/zh active Pending
- 2020-07-03 EP EP20737270.7A patent/EP3994156A1/en active Pending
- 2020-07-03 AU AU2020312230A patent/AU2020312230A1/en not_active Abandoned
- 2020-07-03 BR BR112022000133A patent/BR112022000133A2/pt not_active IP Right Cessation
- 2020-07-03 WO PCT/GB2020/051594 patent/WO2021005339A1/en not_active Ceased
-
2021
- 2021-12-17 US US17/644,931 patent/US20220211760A1/en active Pending
- 2021-12-23 IL IL289334A patent/IL289334A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Cancer vaccines as promising immuno-therapeutics: platforms and current progress | |
| Arab et al. | HER2-positive breast cancer immunotherapy: a focus on vaccine development | |
| Molino et al. | Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses | |
| JP5127224B2 (ja) | 予防又は治療目的のためのｍｈｃクラスｉ拘束性エピトープに対する免疫応答を誘発し、増強し、維持する方法 | |
| JP6945301B2 (ja) | Ｈｐｖおよび関連する疾病のための免疫増強治療ワクチン | |
| US12263210B2 (en) | Immunogenic compounds for cancer therapy | |
| CN115845040A (zh) | 用于免疫疗法的核/壳结构平台 | |
| Cai et al. | Improving cancer vaccine efficiency by nanomedicine | |
| JP2001524928A (ja) | クロスプライミング免疫による天然抗原に特異性を有するｃｔｌの誘導 | |
| JP5709264B2 (ja) | ワクチン組成物および方法 | |
| AU2015233542B2 (en) | A medicament for use in a method of inducing or extending a cellular cytotoxic immune response | |
| Nencioni et al. | Anticancer vaccination strategies | |
| JPWO2021005339A5 (https=) | ||
| JPWO2021005338A5 (https=) | ||
| JPWO2020260897A5 (https=) | ||
| JPWO2020079448A5 (https=) | ||
| US20040022813A1 (en) | Shed antigen vaccine with dendritic cells adjuvant | |
| JPWO2020260898A5 (https=) | ||
| Chamberlain | Prospects for the therapeutic use of anticancer vaccines | |
| JP2022542320A (ja) | ペプチドがロードされたキャリアシステムおよびその使用 | |
| Draganov et al. | 290 Cytokine and immune subset signatures in patients with various solid and hematological malignancies treated with oncolytic vaccinia virus delivered by autologous stromal vascular fraction cells | |
| Panigrahi et al. | Cancer Vaccine for Lung Cancer | |
| AU7909700A (en) | New lymphocytes, a process for preparing the same and their use in therapeutics | |
| RU2684235C2 (ru) | Полиэпитопная противоопухолевая вакцинная конструкция, содержащая эпитопы опухоль-ассоциированных антигенов, фармацевтическая композиция и ее применение для стимуляции специфического противоопухолевого иммунного ответа | |
| CLONES | Genes Coding for Antigens Recognized on Human Tumors by Autologous Cytolytic T Lymphocytes zyxwvutsrqpon |